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Abstract

Cannabis is the most widely used illicit drug, worldwide and also in Afghanistan.
According to United Nation Office for Drug and crime (UNODC) Afghanistan Cannabis
survey (2009), more than half of all drug users interviewed in Afghanistan had used
cannabis in their life time. In this survey around 630,000 people, mostly men, were
documented as cannabis users. On the other hand, cannabis life time use amongst regular
female drug user was 40%. The annual prevalence of cannabis use was 8.1 percent in
male and 0.2 percent in female populations (UNODC Afghanistan Cannabis survey
2009). In Afghanistan cannabis is most commonly used amongst various groups of
individuals, including public transport and truck drivers, and law enforcement personnel,
such as Afghan National Police and Afghan National Army recruits. According to a
Government Accountability Report for the United States Congress in March 2010, the
percentage of Afghan Police recruits who tested positive for drug use, (i.e., marijuana,
hashish and opiates) was 12-40% (Nordland & Wafa, 2010). Cannabis use has been
linked to a myriad of adverse health outcome included but not limited to, increased risk
of schizophrenia, impairment of cognitive functioning, deterioration of motor skills,
weakening of driving skills, adverse pregnancy outcome and increased risk of
cardiovascular and respiratory diseases (Kalant, 2004). The aim of this paper is to
highlight cannabis production, use and adverse health outcomes in Afghanistan and to
propose recommendations for cannabis control and reversal of its negative health
outcomes.
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Chapter I
1.1 Introduction

According to the first-ever United Nation Office for Drug and Crime (UNODC)
report, cannabis production is overtaking opium in Afghanistan (Afghanistan Cannabis
Survey 2009). This fact earmarks Afghanistan as a country with the largest production of
cannabis. According to the UNODC Afghanistan Cannabis survey (2009), more than half
of all drug users interviewed in Afghanistan had used cannabis in their life time. In this
survey around 630,000 people, mostly men, were documented as cannabis users. On the
other hand, cannabis life time use amongst regular female drug user was 40%. The annual
prevalence of cannabis use was 8.1 percent in male and 0.2 percent in female population
(UNODC Afghanistan Cannabis survey 2009). In Afghanistan, Cannabis is most
commonly used amongst various groups of individuals, including public transport
drivers, and law enforcement personnel including Afghan National Police and Afghan
National Army recruits. Based on a Government Accountability Report for the United
States Congress, the upper range of Afghan Police recruits who tested positive for drug
use (i.e., marijuana, hashish and opiates) was 40 % (Nordland & Wafa, 2010)
This widely used drug is not insipid; studies have indicated the epidemiologic link
between cannabis use and risk of schizophrenia. Various studies have documented the
adverse effect of cannabis use and driving skills impairment (Kalant, 2004). Cannabis
smokers have showed increased risk of chronic airway inflammation and airway cancer.
Numerous studies have found the risk of physical and psychological dependency in a
significant portion of cannabis users. Early cannabis use, especially, weekly or daily use
1

predicts future dependence. It is documented that around 7-10 percent of regular cannabis
users were both physical and psychological cannabis dependent. The impact of cannabis
use on cognitive included permanent impacts on recall, information processing, and
major brain tasks in fetus of pregnant cannabis female users (Kalant, 2004).
1.2 Forms of Cannabis

Cannabis is used in various forms: herbal cannabis, this form is used as desiccated
leaves and flowering tops, also known as “ganja, or weed” or “cannabis resin”; the
second form is the squeezed secretion of the herb, known as hashish or in local language
known as ‘charas’; and the third form is the oil cannabis which is a blend made from
concentration or extraction of active constituent of the herb (UNODC Afghan Drug
Survey Executive Summary 2009).
Cannabis is the largest produced illicit drug globally and is seen nearly in every
country worldwide. Almost one fourth of all the worlds’ cannabis is produced in Africa,
particularly in Morocco, South Africa, Lesotho, Swaziland, Malawi, Nigeria, Ghana,
Senegal, Gambia, Kenya and Tanzania. In addition, North and South America produce
less than half of global cannabis demands (UNODC Afghan Drug Survey Executive
Summary 2009).
In term of quantity and geography, cannabis herb is the most widely smuggled
illicit drug worldwide. Around 70 % of world’s cannabis is seized in North America,
especially, in Mexico and United States, followed by 11 % and 10% in Africa and in
South America, respectively. Cannabis resin is the second most trafficked drugs
worldwide. Afghanistan has started recently to exceed Morocco in cannabis production.
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Afghanistan’s cannabis has also been a major alternative for opium crops. Due to less
laborious work, low irrigation needs, high yields and lucrative markets, cannabis is
substituting opium in Afghanistan (UNODC Afghan Drug Survey Executive Summary
2009).
1.3 Prevalence of Cannabis Use Worldwide

Cannabis use is estimated to be between 125 million and 203 million people
worldwide (UNODC, World Drug Report, 2010). In 2009 the estimate of cannabis use in
population aged between 15 and 64 years was 2.8 to 4.5 percent worldwide. Cannabis
use in North America has remained unchanged; but has increased slightly over the past
four years in the United States (UNODC, World Drug Report, 2010). Annual prevalence
of cannabis use in North America is around 10.7 percent amongst people age 15-64;
however, cannabis use prevalence amongst youth has been increased over the past four
years (cannabis review). According to UNODC Afghanistan Cannabis survey (2009),
Afghanistan’s cannabis use prevalence in 2009 was 8.1 percent in male and 0.2 percent in
female population. According to this report around 60 percent of all drug users
interviewed in Afghanistan had the history of cannabis use in their life time whereas 40
percent of women drug users had the history of cannabis use in the past. In addition, this
survey had documented approximately 630,000 people, mostly men, as cannabis users.
1.4 Afghanistan overview

Afghanistan is a land locked country about the size of Texas, is located in south
Asia and sometimes being described as located in the heart of Asia linking South and
East Asia with Central and Western Asia. Afghanistan borders Uzbekistan, Tajikistan,
3

and Turkmenistan on the north, China on the northeast, Pakistan on the south and east
and Iran on the west (Afghanistan Overview). Afghanistan covers 652,230 sq km of area.
The estimated population will be 31,108,077 by July 2013 (CIA - The World Factbook).
Afghanistan is divided into 34 provinces and 397 Districts (Afghanistan Overview).
Afghanistan is world’s 41st biggest country in size. Kabul is the capital of
Afghanistan, which is located in the central part of Afghanistan in Kabul province. Due
to its strategic location at the crossroads of the major trade routes, Afghanistan has been
the place for commerce and thus attractive to invaders since the sixth century BC.
Afghanistan is divided by Hindokush Mountains into three main regions: 1)
central highlands that account for roughly 60% of the country’s area, 2) the southwestern
region, which include 25% of the land; 3) and the minor northern grasslands areas, which
covers the country’s most productive land. Average life expectancy at birth for total
population is 50.11 years, male: 48.81 years, and female: 51.47 years. Afghanistan
natural resources include “natural gas, petroleum, coal, copper, chromite, talc, barites,
sulfur, lead, zinc, iron ore, salt, precious and semiprecious stones” (CIA - The World Fact
book). Due to four decades of war and turmoil in the country, these resources have not
been properly explored and utilized.
1.5 Economy
Afghanistan’s main economy is dependent on agriculture which generates two
thirds of national income and employs almost 85 percent of the country’s population.
Most land cultivation is carried out in oases and valleys, and the characteristic of livestock breeding is in a semi-nomadic form. Main branch of agriculture is relied on
4

livestock breeding; it represents almost one third of agricultural production. The
country’s crop production is dependent on irrigated lands. Half of these lands are still
faced with shortage of water. Current irrigation systems of Afghanistan was established
after 1945 (Afghanistan Overview). Afghanistan’s main crop is wheat, corn and rice, but
due to continuing war and economic constrain these crops have been replaced by opium
and cannabis, especially, in northern and southern regions.
Afghanistan’s map

Source: - http://www.173rdairborne.net/images/afg_ad1.gif
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1.6 Geography of Cannabis Production and Use in Afghanistan

According to the Ministry of counter narcotic and the United Nation Office for
Drug and Crime “MCNUNODC” cannabis survey (2011), 23 provinces in Afghanistan
were identified as high risk areas for cannabis cultivation. Ground information from 11
other provinces indicated that cannabis cultivation either did not exist or was negligiblelimited to kitchen garden or other form of small-scale – cultivation.
The survey was conducted between July and September 2011 in 1,500 villages
where farmers and headmen were interviewed, and was substantiated by yield studies and
satellite image interpretations. The yield observation study was undertaken in December
2011-January 2012, when the processing of cannabis resin production took place and this
study was preceded by headmen and farmers interview during the villages’ surveys. The
overall cannabis area estimate was based on the interpretation of 155 very high-resolution
satellites images and village survey (Afghanistan Cannabis Survey 2011)
The cannabis cultivated areas in 2011 were estimated to be 12,000 hectares (8,000
– 17,000 ha). This result was slightly lower compared to 2010 estimate which was 9,00029,000 ha. The covered areas that were included in estimation were due to large scale
mono-crop cannabis cultivation and “commercial” production. Small-scale cultivation,
“such as in kitchen gardens, flower pots, along the walls of compounds, along the
boundaries of fields, “wild cannabis” or cannabis intercropped with other crops in the
same field at the same time, is not part of the area estimates of this survey” (Afghanistan
Cannabis Survey 2011). Cannabis was found to be cultivated in 21 provinces out of 23
6

high risk provinces for cannabis cultivation. Out of 21 provinces where cannabis was
found to be cultivated, 14 provinces were substantiated by satellite images and 7
provinces were covered by the villages’ surveys only. In these surveys more than one
third of cannabis was cultivated in the southern region. This difference by region was due
to opium cultivation; however, cannabis cultivation was also found in several poppy free
provinces, but, there was an explicit geographic association between cannabis and opium
cultivation in provincial level (Afghanistan Cannabis Survey 2011).
Most commercial Cannabis cultivation in 2011, similar to 2009 and 2010, was in
the southern region, where most of opium (78%) was also cultivated.

Daykundi,

Helmand, Kandahar, Urozgan and Zabul provinces were the main southern provinces
where cannabis was cultivated. There was a clear geographical association between
opium and cannabis cultivation at the provincial level. Similar association existed at a
household level with almost two thirds of cannabis-growing households (58%) also
reported poppy cultivation in the preceding season (Afghanistan Cannabis Survey 2011).
Commercial Cannabis Cultivation Status, by Province, 2011

Source: - MCN-UNODC Afghanistan Cannabis Survey, 2011
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1.7 Cannabis Use

Similar to regional differences, northern and southern parts of Afghanistan have
the highest prevalence of cannabis use and these areas are also the major producers of
cannabis in Afghanistan (Afghan-Drug-Survey-2009-Executive). Men are the major
cannabis users in Afghanistan; in 2009, 8.1 percent of men were documented as cannabis
users. The prevalence has been stable for the last four years; in 2005 the prevalence of
cannabis use was 8 percent and only 0.1 percent increment has been observed over the
course of past four years. Around 70 percent of these cannabis users reported regular
daily cannabis use while 25 percent reported 2 to 4 days in a week in the past month. In
contrast, the number of women cannabis users was much smaller than men cannabis
users; the prevalence of women cannabis users was 0.2 percent, which has doubled since
2005. Twenty five percent of women who used cannabis reported daily cannabis use, 50
percent 2 to 4 days a week and the remaining 25 percent reported 1 day a week of
cannabis use, (Afghan-Drug-Survey-2009-Executive).
The rate of cannabis dependency was higher in men cannabis users than in
women cannabis users. The rate of cannabis dependency was three times more common
in men than in women cannabis users. The use of cannabis, in comparison to other illicit
drugs, started at early age around 18-19 years, whereas the mean age for heroin use was
24 years of age. Most cannabis users were educated, 50 percent of cannabis users in
Afghanistan reported having primary education and around 30 percent had secondary
education. In contrast, other drug users, such as opium and heroin users, were mainly
uneducated and illiterate. Similarly, cannabis users had fewer psychosocial problems
8

than opium and heroin users in Afghanistan. However, cannabis users still face some
kinds of physical, psychological and relationship problems due to cannabis use (AfghanDrug-Survey-2009-Executive).
Cannabis Use by region in Afghanistan, 2009

Source:- Afghan Drug Survey Executive Report 2009
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Chapter II
2.1 Review of Literature

Cannabis use has been linked to myriad negative health outcomes; studies have
shown the epidemiologic link between cannabis use and schizophrenia (Kalant, 2004). In
several studies the negative impacts of cannabis use and impairment of driving and motor
skills have been highlighted. In various studies the risk of chronic airway inflammation
and cancer due to Cannabis smoking has also been stressed. Numerous studies have
showed the risk of physical and psychological dependency in a significant portion of
cannabis users. Early cannabis use, especially, weekly or daily use has predicted future
dependence. It has been documented that around 7-10 percent of regular cannabis users
have been both physical and psychological cannabis dependent. Cognitive impairment
included permanent recall issues, processing of information and major function of fetus
brain of pregnant cannabis users (Kalant, 2004).
2.2 Cannabis Use and Risk of Schizophrenia

Psychosis is defined as mental state characterized by the following features:
delusions, which are false beliefs; hallucinations, which are sensation of things in the
absence of true environmental stimulation, such as hearing voices and seeing objects
without true stimuli; and gross disorganization of speech and/or behavior which does not
make sense (American Psychiatric Association 2000).
Discrete psychotic disorders that can be experienced at any time in life should not
be considered as psychotic disorder; such indications may be clinically insignificant,
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especially, when they are transitory and brief. However, when these symptoms are
severe, numerous in number and occurring simultaneously and persist for longer period
of time, then such psychotic disorder can be diagnosed as schizophrenia. To diagnosis
schizophrenia the following conditions should exists. (a) In addition to ‘negative
symptoms’, which include a number of symptoms such as emotional instability, mutism
(lack of speech), and/or absence of motivation; presence of two or more distinguishing
symptoms “(delusions, hallucinations, disorganized speech, grossly disorganized or
catatonic behavior)”, for a considerable period of time in a month; (b) loss of function in
social or occupational settings; and (c) persistence of these signs constantly for at least
six months (American Psychiatric Association, 2000)
Increasing use of cannabis has been seen amongst schizophrenic patients. in
recent assessment of more than 50 treatment studies, amongst patient with psychosis,
prevalence of cannabis use was 29.3 percent compared to 4 percent in the general US
population (B. Green, Young, & Kavanagh, 2005). In addition, cannabis use has been
shown to be linked with two time increase in odds ratio of developing schizophrenia and
associated disorders in prospective studies (Arseneault, Cannon, Witton, & Murray,
2004). In addition, the link between cannabis sue and acceleration of schizophrenia onset
has been noticed in retrospective studies (Hambrecht & Häfner, 2000). Despite the
ambiguous mechanism of psychosis, these studies suggest the important role of cannabis
use in psychosis causation. In one study, the likelihood of cannabis use and stable
neurological changes in schizophrenic patient was not found; however, the transient
adverse outcome of neurochemical effects was found which was prominent in people
with genetically vulnerability to psychosis (Foti, Kotov, Guey, & Bromet, 2010).
11

The relationship of cannabis use and schizophrenia and/or psychotic symptoms
has been noticed for some time. In a study conducted by Hambrecht and Hafner (2000)
the relationship of cannabis use and psychotic symptoms was found in bunch of analysis
in early psychosis patients. Several potential types of correlation between cannabis use
and psychotic symptoms and/ or schizophrenia were proposed by them. The use of
cannabis was proposed to reduce the vulnerability threshold of schizophrenia and
enhance the susceptibility to psychosis in people without known genetic liability to
schizophrenia. The dose response association between quantity of cannabis used in
adolescence and the following risk of emerging schizophrenia was studied by Andreasson
et al (1987). In more recent studies that controlled for other drug use such as
amphetamine and personality trait, it was concluded that 13% of schizophrenia might be
prevented if cannabis could be removed from the ‘schizophrenia equation’ (Cohen,
Solowij, & Carr, 2008).
Van Os et al (2002) in a balanced prospective study found that in people, who
were free from psychotic symptoms, the length of lifetime exposure to cannabis was a
significant risk factor for the developing of psychosis. In people with no genetic liability
to psychosis, cannabis use was linked in up to 50 percent of cases to develop psychosis.
In another study done by Arsenault et al. (2003) it was found that use of cannabis
increased the risk of developing schizophrenic symptoms after controlling for symptoms
of pre-existing psychosis and it was also noted that the commencement of cannabis use at
early age (prior age 15) could pose great risk for developing schizophrenia (Arseneault et
al., 2002). Cohen and his colleague mention that one reason for this can be the
neurodevelopmental process in which the cognitive, developmental, emotional, and
12

behavioral measures shift to adulthood and can easily be affected by cannabis use,
specifically, frontal and limbic systems would be more sensitive to these changes (Cohen
et al., 2008).
In

many

cohort

studies

the

association

between

cannabis

use

and

psychosis/schizophrenia, over the past several years, has engrossed substantial
consideration in the research, media and the community (David M Fergusson, Boden, &
Horwood, 2006). Cannabis use is causally related to psychotic disorders such as
schizophrenia and often has been interpreted as causative factor in these studies (Smit,
Bolier, & Cuijpers, 2004). The contributory part of cannabis use in psychosis has been
indicated in many reviews or the links between such relationship have often not been
excluded (Moore et al., 2007).
However, some uncertainties that whether cannabis use contributes to psychotic
disorders emergence, due to some mythological limitations, are controversial. At the
same time as few published cohort studies have evaluated the strengths and weaknesses
of these methodologically diverse cohort studies, the comparative qualities and
weaknesses might impact the interpreted relationship of cannabis use and psychosis
(McLaren, Silins, Hutchinson, Mattick, & Hall, 2010).
For the evidence to demonstrate that a particular association is casual, these need to be
shown:
1. Strength of correlation.
2. Consistency
3. Temporality
13

4. Biological gradient
5. Coherence.
6. Specificity
7. Plausibility
8. Analogy
(McLaren et al., 2010).
2.3 Swedish Conscript Study
The development of psychosis was found in the first cohort study which predicted
cannabis use and subsequent psychosis in a sample male Swedish Conscript. These
conscripts who were evaluated for substance use and psychiatric diagnosis at age 18 were
tracked for more than 10-year period inpatient admission for schizophrenia (Andréasson,
Allebeck, Engström, & Rydberg, 1987). At age 33 those who used cannabis 50 times or
more had six times more rate of hospitalization for schizophrenia than those who did not
use cannabis. In addition, the rate of hospitalization for schizophrenia was three times
more in those who had used cannabis between 10 and 50 times. However, when some
confounders such as, “social and family background, and other substance use were
controlled, the rate of hospitalization for schizophrenia amongst those who had used
cannabis less than 10 times was reduced to 2.3 (95% CI: 1.0–5.3) and was no longer
statistically significant. The adjusted odds ratio for those who had used cannabis more
than 50 times was not reported” (McLaren et al., 2010)
Cannabis use 1-10 times (relative risk: 1.5, 95% CI: 0.6–3.3) was less significant
as variable than others which best predicted schizophrenia. Psychiatric diagnosis at the
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baseline and separated parents were the variables that best predicted schizophrenia. The
duration of cannabis use was not covered in this study; however, during the follow-up
period at conscription study cannabis use was strongly linked with later treatment for
cannabis and other substance use (McLaren et al., 2010).
.
Pre-existing psychotic or other psychiatric signs at baseline were not measured
in the study and it is difficult to decide whether cannabis use predict psychotic symptoms
or not. It is also challenging to account premorbid personality traits for both cannabis use
and development of schizophrenia. Other potential confounding that were serious
psychogenic substances such as amphetamine was also not controlled for (McLaren et al.,
2010).
Another study with relatively longer follow-up period was undertaken as reanalysis, in which stimulants and other substance use including alcohol were controlled;
cannabis persisted as predictive factor for schizophrenia in a dose-dependent manner. The
rate of hospitalization, because of schizophrenia, was three times more for those who had
used cannabis 50 times or more at age 18 than those who did not use cannabis (Zammit,
Allebeck, Andreasson, Lundberg, & Lewis, 2002). An inclusive extent of premorbid
social integration, which did not impact the association between cannabis use and
schizophrenia, was included in this study (McLaren et al., 2010).
A multi-site survey of population was launched in the United States between 1980
and 1984 in which the presence of psychotic disorders were measured through the
Diagnostic Interview Schedule (DIS) (Tien & Anthony, 1990). This survey, which
measured substance use, social and demographic characteristics, was launched at the
15

baseline and at one year follow-up. For the evaluation of cannabis use and the risk of
psychotic symptoms, participants with one or two symptoms at baseline were disqualified
and ‘cases’ (subjects with at least single psychotic symptom at follow-up year) were
compared with controls (i.e., those without psychotic experiences at follow-up). After
controlling for social and demographic factors (e.g., sex, education, marital status, and
occupation), baseline substance use (regular cocaine and alcohol use) and psychiatric
disorders, overall, 477 cases were matched with 1818 controls whose age range was
between 18 and 49. This survey showed cannabis use to be linked with two-fold risk of
psychotic symptoms one year later (McLaren et al., 2010).
The Netherlands Mental Health Survey and Incidence Study (NEMESIS) found
in population cohort of cannabis users at baseline whose age range was between 18 and
64 years, the experience of mild psychotic symptoms at follow-up (three years later, OR:
2.11, 95% CI: 0.78–5.71, not significant). More significantly, after controlling for age,
sex, socioeconomic status, and other drug use, 17 times more clinically significant
psychotic symptoms were reported by them three years later (OR: 16.93, 95% CI: 3.33–
86.13); and they were over 10 times more likely to need care for psychotic symptoms
than those who did not use cannabis (van Os et al., 2002).
In addition, the link between cannabis use and psychosis was dose dependent.
Notably, those who were included in the NEMESIS sample, all of them were psychotic
symptoms free at the baseline. Those who had psychotic symptoms at the baseline were
studied separately and they showed stronger psychotic symptoms following cannabis use
than those who did not use cannabis. The author concludes that the acute impact cannot
predict the link between cannabis use and psychotic symptoms and adds that the
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relationship between cannabis use and risk of psychotic symptoms is based on long-term
cannabis use (McLaren et al., 2010).
Cannabis use, at age 11, 15 and 18, and preceded Psychotic symptoms along with
schizophrenic symptoms and diagnosis of schizophreniform disorder at age 26, were
studied in a study known as “The Dunedin Multidisciplinary Health and Development
Study” that has been running in New Zealand since the 1970 as the birth cohort study. In
this study, 759 males and females born between 1972 and 1973 were studied for
mentioned psychotic symptoms. Schezophreniform and schizophrenia are alike in terms
of symptoms but the duration of symptoms differ; the duration of symptoms for
schizophrenia is at least six months whereas the duration for schizophreniform symptoms
is one month and it does not necessarily lead to occupational and socials issues
(American Psychiatric Association, 2000). In this study, subjects who had started
cannabis use at age 15, even after controlling for other drug use and childhood psychotic
symptoms, had more symptoms of schizophrenia at age 26 than those who did not use
cannabis. In addition, the link between schizophriniform diagnosis and cannabis use at
age 15, but not 18, was noticed; however this association was weaker after controlling for
childhood psychotic symptoms in the analysis (Arseneault et al., 2002).
Another cohort study, known as the Dunedin birth cohort, proposed that genetic
predisposition could lessen cannabis effects on psychosis risk. Those who had functional
polymorphism of a gene (catechol-O-methyltransferase, or COMT), which involved in
the dopamine system (the neurotransmitter system implicated in schizophrenia), were 10
times more at the risk of developing schizophriniform disorders by age 26 than those who
did not possess this gene (Caspi et al., 2005). The author reasoned that the environmental
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risk factor, such as in this case adolescent cannabis use, was a prerequisite for
development of psychosis amongst those who had the particular polymorphism.
Increased risk of schizophriniform was not increased in participants who were Val/Val
allele and did not use cannabis (McLaren et al., 2010). This result has been failed to be
replicated in a large case–control study by Zammit et al. (2007).
It should be noted that psychotic patients can also use cannabis for the alleviation
of some of their psychotic symptoms. However, self-medication hypothesis has not been
shown in studies as the most plausible explanation for the relationship between cannabis
use and psychosis. In a recent study in Australia the bidirectional relationship between
psychotic patient and cannabis use was found. In this study relapse of psychotic
symptoms was predicted with cannabis usage, and cannabis consumption relapse was
predicted with psychotic relapse, regardless of medication and other drug use (Hides,
Dawe, Kavanagh, & Young, 2006)
2.4 The Effect of Cannabis Use on Vehicle Crashes

Tetrahydrocanabinol (THC), an active ingredient found in cannabis, results in
impairment of driving skills and this has been traditionally established in experimental
and epidemiologic studies. The impairment of cognition, psychomotor function and
actual driving performance in a dose related manner after cannabis use and concentration
of THC has been repeatedly shown in experimental studies. These impairments were
dose related; for instance, 300g/kg of THC had the same effect as of blood alcohol
concentration (BAC) ≥0.05 g/dl, which in most European countries is the legitimate limit
for driving under the influence. Higher doses of THC, i.e., >300 g/kg, which has not been
systemically studied, may have stronger effect on driving impairment. THC had greater
18

impact on highly automated behaviors, such as road tracking control, than on complex
driving skills that needed conscious control. The finding of epidemiological studies and
experimental studies on the effect of cannabis (THC) on vehicle crashes is different. The
findings of experimental studies have been reinforced by case-control studies, but
capability studies have shown little proof about the link between cannabis use and vehicle
motor crash. However, after determination of presence of an inactive metabolite of THC
in the blood and urine of crashed drivers several days after smoking cannabis, most
culpability surveys established link between previous cannabis use and vehicle crashes.
In surveys which documented recent cannabis use by measuring THC in the blood of
crashed drivers; the THC presence in the blood of crashed drivers, especially, at greater
concentration, was linked to three to seven times more crashes than those who did not
have THC concentration in their blood or did not use cannabis or alcohol. Recent
cannabis use may increase the likelihood of crashes but old cannabis use does not, these
findings have been suggested in these epidemiological studies. The findings of
epidemiological studies and experimental research are the same concerning the effect of
combined alcohol and cannabis use in traffic. The effects of combined use of alcohol and
cannabis are greater than the individual use of either drug. They both, when used jointly,
produced severe impairment of intellectual, psychomotor, and actual driving performance
in experimental studies and heightened accident risk in epidemiologic analyses
(Ramaekers, Berghaus, van Laar, & Drummer, 2004).
The prevalence of cannabis use, THC concentration in the blood of drivers who
had vehicle crash, has been reported to be between 4 and 14 percent. These findings are
reported from the surveys in different localities (Ramaekers et al., 2004). However,
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higher concentration of THC has been reported in young males in larger American cities
post vehicle crashes (Williams, Peat, Crouch, Wells, & Finkle, 1985).
The likelihood of crashes after the combined use of cannabis and alcohol are
greater than the use of either drug alone. However, Lack of an appropriate control group
further limits the findings in these studies. These studies only show the presence of these
substances in the blood of drivers post (fatally) crashes. the absence of a control group,
which can yield comparable data from general driving population, does not validate the
prevalence measure of THC or other substances in causing traffic crashes (Ramaekers et
al., 2004).
Despite showing the link between combined substance use, (i.e., alcohol and
cannabis use and motor vehicle accident), culpability surveys do not show the increase
rates of crashes after use of cannabis alone. However, culpability surveys show the
association between cannabis use and crashes after finding higher concentrations of THC
(Terhune et al., 1992). For instance, in two studies by Hunter et al., (1998) and Drummer
et al., (2003), recent cannabis use was confirmed by THC concentration in the blood
drivers post crashes. Both studies showed the link between higher concentration of THC
and increase likelihood of crashes (Ramaekers et al., 2004).
Similarly, case-control studies show a positive relationship between cannabis use
and crashes. In a case-control study done by Mura et al. (2003), THC was compared
among injured drivers and control subjects, who were recruited from emergency
departments in six French hospitals. In this study, sample of 1,800 drivers, 900 cases and
900 controls were studied. The cases were the drivers who entered the emergency
department due to non-fatal accident and the controls were visitors of the same
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emergency department due to non-traumatic reasons. Cases and controls were controlled
for age and sex and when averaged overall all age groups, 10 percent of cases and 5
percent of controls had THC >1 ng/ml, no other drug including alcohol was found in their
blood. Fifteen percent of the cases and 6.7% of the controls had THC in their blood when
they were considered for age 27 and younger and the odds ratio of 2.5 and a 95% CI
ranging from 1.5 to 4.2 was noted. In cases that had both THC and alcohol (BAC > 0.05
g/dl) the OR was doubled (95% CI: 2.0–10.7) (Mura et al., 2003).
In summary, dose related THC has been linked to the impairment of psychomotor
function, and actual driving performance. THC at doses of up to 300 g/kg was
comparable to the impairing effects of an alcohol level a BAC ≥ 0.05g/dl, which is the
legal limit for driving under the influence in most European countries. The relationship of
recent cannabis use and vehicles crashes has been documented, especially, at higher
doses; however, there is no finding concerning past cannabis use and motor vehicle
accidents. Adverse effects of THC are more prominent in highly automated driving
behavior, as compared to more complex driving tasks that require conscious control
(Ramaekers et al., 2004).

2.5 Cannabis as a Gateway Drug

Gateway sequence can be an independent risk factor for substance use; for
instance, one who is already on a drug is at greater risk for the subsequent use of another
substance and this subsequent use can be explained by the sequence that one has entered
rather than by opportunity for use (Kandel & Faust, 1975). Two types of evidence can
support the gateway theory: the noted time order between uses; for instance, in most
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cases prior cannabis use precedes the use of other illicit drugs (OID); and the strength of
the relationship between cannabis use and other illicit drug use (Lessem et al., 2006).
To propose that cannabis use can lead to the development of other illicit drugs in
naturalistic studies is difficult, because randomization of subjects to the experimental
conditions is often problematic. However, quite a few research studies have been
launched to explore cannabis use as the cause of initiation of other illicit drugs in
epidemiological samples.
Shrout (1998) proposed that association, isolation, and direction are the conditions
that establish causation. Therefore, indication of cannabis use, which links to the
progression of other illicit drug use, even after controlling for other confounders, validate
the condition of association and isolation; however, they cannot eliminate other
unmeasured variables to be the causal factors. In addition, longitudinal studies owing to
the temporal sequence of events (i.e. that cannabis use precedes other illicit drug use) can
fulfill the condition for direction (Lessem et al., 2006).
In a study by Yamaguchi and Kandel, (1984), despite controlling for other
covariates, it was found that cannabis use was associated with use of other illicit drugs.
Likewise, Fergusson and Horwood, (2000) explored the prediction of cannabis use and
subsequent other illicit drug use after controlling for family, social, educational, and
behavioral background. They found that other illicit drug use was 59.2 times more likely
in cannabis users, (who reported using cannabis on more than 50 occasions) than in noncannabis users.
In another study by Lessem and his colleagues ( 2006), it was found that young
cannabis users were twice as likely to use illicit drugs that non-cannabis users. They
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mentioned that shared environmental factors mediated much of the relationship between
adolescent cannabis use and young adult drug users. In this study, the finding was stable
even after controlling for familial environmental and other measured factors. Mayet and
his colleagues, (2012) found that cannabis use could tremendously increase the risk of
initiation of other illicit drugs (OID). In their study they found that the risk of starting
other illicit drugs amongst cannabis experimenter was 21 times, and amongst daily
cannabis users was 124 times higher than in non-cannabis users. They mentioned “the
results of this study provide a confirmation of a stage process in drug use, mediated by
cannabis and liable to lead to OID experiment. This is compatible with the literature on
the gateway theory, but goes further by modeling the entire sequence of use. OID
experiment could be a consequence of initial opportunity to use the more accessible illicit
drug, cannabis.” (Mayet et al., 2012)

2.6 Cannabis Use and Crime

Several studies have indicated the link between cannabis use and a range of
adverse social outcomes, such as poor educational attainment, unemployment, personal
relationship issues, and reduced life satisfaction. However, some studies find
inconsistencies in these outcomes and other studies question these findings. Due to large
mythological challenges and differences in study design (i.e., cross sectional studies and
even in population based studies), it is hard to mitigate contributing confounding in this
domain (Pedersen & Skardhamar, 2010). Nonetheless, the evolving idea in some studies
indicates that the effects of cannabis use can be more pervasive than it was thought
previously. During the last two decades, some attentions have been directed to cannabis
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use and crime. The sophisticated link of cannabis use and crime has been addressed in a
number of studies. In some studies conduct problems have been indicated as a risk factor
for subsequent cannabis use while other studies have linked cannabis use with increased
delinquent activity and crime (Pedersen & Skardhamar, 2010).

Pedersen and Skardhamar, (2010) found the strong relationship between cannabis
use and later registered criminal charges in young adulthood. They mention that this
finding was noted even after controlling for the following confounding varaibles, such as
socio-economic background of family, support and monitoring role of parents, career and
educational achievement, past criminal charges, conduct problems and history of living
together and marriage. They further report similar findings after adjusting for alcohol and
other illicit drug use. However, they reported insignificant findings of a link between
cannabis use and criminal charges after eliminating all drug specific charges in their
model. They conclude that “cannabis use in adolescence and early adulthood may be
associated with subsequent involvement in criminal activity. However, the bulk of this
involvement seems to be related to various types of drug-specific crime. Thus, the
association seems to rest on the fact that use, possession and distribution of drugs such as
cannabis is illegal. The study strengthens concerns about the laws relating to the use,
possession and distribution of cannabis” (Pedersen & Skardhamar, 2010).
In another study by Green and his colleagues (2010) the interaction of heavy
adolescent cannabis users and non-users with in the justice system were compared. They
found that heavy cannabis users had about two times an increased record of arrest than
non-users. On average, the mean and median of arrest in heavy adolescent cannabis users
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were 6.5, and 4 respectively, while the mean and median of arrest in light/non-users were
4.5 and 3, accordingly. In addition, the likelihood of arrest at a younger age for heavy
cannabis users was more than for light/non-cannabis users. The mean age of first arrest
for heavy users was 21.4 years compared to 22.5 years for light/non-users. They noted 2
to 3 times more rates of arrest for three different kinds of crimes including violent,
property, and drugs in heavy cannabis users than in light/non-users.
They add that the rate of arrest for violent crime in heavy cannabis users was 31.5
percent, almost two times higher than light/non-users (17.8%). Similarly, the rate of
arrest for property crime in heavy cannabis users was 40.5%, two times more than that of
light/non-users (21.3 %). The rate of arrest was two times higher (28.7%) for drug related
crime in heavy cannabis users than in light/non-users (10.3%). They found similar
patterns in self-reported crime; they established that around 60 percent of heavy cannabis
users reported being involved in violent crime compared to 45 percent of light/non-users.
Approximately, 70 percent of heavy cannabis users were involved in property crime
compared to 47 percent of light/non-users. They also found that the involvement of heavy
cannabis users in drug dealing was around 30 percent compared to approximately 12.3
percent of light/non-users. Likewise, they determined that around 42 percent of heavy
cannabis users had a record of incarceration compared to 16.6 percent of light/non-users
(K. M. Green et al., 2010).
2.7 Cannabis Use and Education Attainment

The use of cannabis and its association with educational attainment has been
studied. Many studies have explored the importance of the relationship of cannabis use
and the scope of educational attainment. The link of cannabis use and low educational
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performance including lower grade point average, low school satisfaction, negative
attitudes to school, increased rates of school absenteeism and poor school performance,
have been observed in majority of these cross sectional studies (Lynskey & Hall, 2000).
The association of cannabis use and poor educational performance cannot be validated
based on these studies because most of these studies were cross sectional. However, the
relationship of cannabis use and poor educational performance has also been found in
many prospective longitudinal studies. Several prospective longitudinal studies have
indicated the link between cannabis use and poor educational performance including
early school dropout. Even after controlling for several confounding, this link has
remained stable. Several possible mechanisms have been postulated by experts for
cannabis use and poor educational attainment. One of these mechanisms can be
“motivational syndrome” or other cognitive and memory problems, which is caused by
cannabis use. However, there is little evidence to support these hypotheses. Another
reason for cannabis use and poor educational attainment can be that of the social context
within which cannabis is used. For instance, cannabis use can be linked with an anticonventional life-style characterized by bonding with criminal and substance users peers
which subsequently leads to early school leaving, run away from parental home and early
parenthood (Lynskey & Hall, 2000).
In another study by Fergusson and his colleagues

(2003) cannabis use was

associated with premature school withdrawal without being able to graduate, inability to
get into university and getting university degree. They reported that this association was
stable even after controlling for confounding factors. “When due allowance was made for
pre-existing levels of cannabis use there was no evidence to suggest the presence of
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reverse causal pathways in which lower educational achievement led to increased
cannabis use” (Fergusson et al., 2003). They concluded that their finding support the
view of cannabis use and low educational attainment, especially, in young people. They
propose that this effect may likely be due to social context within which cannabis used
rather than the direct effect of cannabis on memory and cognitive ability (David M
Fergusson et al., 2003).
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Chapter III
3.1 Discussion, Analysis, Intervention, Prevention and Recommendation

As mentioned above cannabis use can be linked to various negative health
outcomes, including but not limited to, increased risk of schizophrenia, psychosis,
impaired motor control, risk of increased impairment of driving skills - with consequent
vehicle crashes; negative education attainment, and increased rate of crime. However,
there are few studies available to relate these outcomes to cannabis use in Afghanistan.
Nonetheless, we can extrapolate the negative outcome of cannabis use in Afghanistan
from the following facts:
According to UNODC cannabis survey (2009) the prevalence of cannabis use in
2009 in Afghanistan was 8.1 % and 0.2 % in male and female, respectively. Likewise, it
is estimated that over two million people are suffering from schizophrenia, depression,
and bipolar disorder in Afghanistan (WHO 2009-2013). Schizophrenia and substance use
are the most diagnosed disorders in mental hospitals in Afghanistan (WHO 2004). In 5
community-based psychiatric inpatient units available in the country, schizophrenia
composed

45 % of patients and mood disorders 21% of patients with unknown

admission length ( Afghanistan WHO AIMS Report ).
“The distribution of diagnoses varied across facilities: in outpatients facilities
neurotic disorders and other disorders were most prevalent, within inpatient units’
schizophrenia and substance abuse were most frequent diagnose in mental hospitals
(Afghanistan WHO AIMS Report ).
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Source:- ( Afghanistan WHO AIMS Report )

Due to the scarcity of data and research, it is difficult to quantify cannabis use as a
cause for schizophrenia and other mental problems in Afghanistan; however, we can
deduce from prevalence of cannabis use and increased prevalence of diagnosis of
schizophrenia in Afghanistan that cannabis use has may likely be linked with increased
risk of mental illness such as schizophrenia. The better measures can be drawn from
subsequent changes in cannabis use and the estimate of schizophrenia in this country.
Arseneault and his colleague (2004) indicate that prospective studies find that
cannabis use is linked with two times an increase in the odds of developing schizophrenia
and associated disorders. Considering this finding, cannabis use may likely create a major
mental health problem for the armed forces of Afghanistan, because according to a
Government Accountability Office report for the United States Congress in March 2010
the prevalence of cannabis and opiate use in Afghan Police recruits was 12 to 41 percent
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(Nordland & Wafa, 2010). It is a major concern for the Afghan defense and interior
ministries, because it shows that cannabis use is five time more common in Afghan
police than in general population. It has been shown that cannabis use can result in brief
psychotic experiences, such as hallucinations and paranoia, even in healthy individuals
(A Complex Link Between Marijuana and Schizophrenia - TIME ). In view of this
phenomenon, the health consequences of cannabis use in armed forces would be
significant risk factor for irregular behavior.
During the last several years, evidence has shown the increasing incidence rate of
attacks, also known as “green on blue attacks” or “insider attacks”, of Afghan security
forces including Afghan National Army and Afghan National Police on US and NATO
forces in Afghanistan. From 2007 to 2012, there have been 71 documented “green-onblue” attacks. “It is difficult to draw definitive conclusions about the principal causes of
these attacks given the small total number of incidents, but there are discernible trends”
(Afghanistan: Green-on-Blue Attacks in Context, Institute for the Study of War ). Few
studies have been done so far to explore the cause of these attacks, however, the use of
cannabis and consequent psychotic symptoms such as hallucination and paranoia, have
not been excluded.
In addition, increased cannabis production and easy availability, even its
handiness in grocery shops in most part of the country, has increased in the number of
cannabis users, especially, amongst drivers. According to some unofficial surveys, more
than 70 percent of drivers (i.e., public transport, private taxi, and truck drivers) are
addicted to cannabis. Studies have shown that dose related cannabis use has been linked
to the impairment of psychomotor function, actual driving performance, and vehicle
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crashes. Similarly, Afghanistan vehicle crashes claim several hundred lives annually,
which is a significant cause of death following the ongoing war in this country. From July
2012 to June 2013 around 214 people have been killed and around 218 people have been
injured due to vehicle crashes in Afghanistan (Afghanistan Accident - Crash Reports).
There are insufficient studies to show the link between cannabis and vehicle crashes and
subsequent mortality and morbidity in Afghanistan. However, considering the highest
prevalence of cannabis use amongst drivers and the significant impacts of cannabis use
on driving skills, the likelihood of a link between cannabis use and vehicle crashes in
Afghanistan cannot be ruled out. Research is needed to explore the link between cannabis
and vehicle crashes and related mortality and morbidity in Afghanistan.
Likewise, the association between cannabis use and crime and educational
attainment is also not fully explored in Afghanistan. However, evidence suggests that
there are links between cannabis use and increased crime rates. Due to ongoing turmoil in
Afghanistan, cannabis use may likely have significant impacts on increasing the crime
rate and low education attainment, especially, amongst 20 to 28 years old individuals.
The Afghanistan population literacy rate is 28.1%. The male literacy rate is 43.1%
and the female literacy rate is 12.6 (CIA - The World Factbook). This means that more
than two third of Afghans are illiterate and cannabis use might likely have had its
contribution in this process which has been unmapped. This is very important to measure
the impact of cannabis use on educational attainment in Afghanistan. Moreover, Studies
are needed to measure the increased rate of crime and low education attainment amongst
young adult in connection with cannabis use.
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3.2 Recommendation

In order to mitigate cannabis production, use, and its health consequences in
Afghanistan, multi-approach strategies need to be adopted by various governmental and
non-governmental entities, including the ministry of counternarcotic, ministry of health
and ministry of defense. This multi-approach process can be applied through the
following recommendations:1. Public education programs can play an important role in the control of illicit drugs,
especially, in the control of cannabis. As 2/3 of the population in Afghanistan are
illiterate and are unable to appreciate the adverse outcome of cannabis use; therefore,
they are health professionals, public health workers, religious scholars, such as Imams
(Mullahs) and tribal elders, who can increase awareness concerning the negative health
outcomes of cannabis.
2. Health workers can present evidence based ill effects of cannabis on health and they may
change the common view concerning cannabis use and the disadvantages, and thus
playing a positive role in cannabis harm reduction.
3. Most people, especially, in remote districts, do not consider cannabis as harmful
substance and even educated people have little information about the relationship of
cannabis use and mental illnesses, such as psychosis, depression and anxiety. In order to
educate people concerning the adverse outcomes of cannabis use; media need to be
involved in this process and need to spread the message. This approach can be
implemented in cities through print and digital media while in remote district where such
facilities are not available, radio, religious scholar such as Imams (Mullahs) and local
heads of the areas can be included as role players in propagation of the message.
32

4. Spreading of messages through prominent figures, such as tribal elders and Imams
(Mullah), can be effective for reducing cannabis production and use. In a cannabis survey
in Afghanistan by UNODC (2011) the majority of farmers, who had ceased cannabis
cultivation, were convinced that cannabis cultivation was Haram (taboo) in Islam.
Twenty one percent of farmers, who ceased cannabis cultivation in 2011, were convinced
that its cultivation was harm (banned in Islam), 19 % left cannabis cultivation due to
government ban while 7% quit cannabis farming due to tribal elders encouragement
(UNODC 2011). So, if Imams are employed in this process and provided with a monthly
regular salary, it would significantly reduce the production and use of cannabis in
Afghanistan. The salary of these Imams would be a trivial amount in comparison for the
fund spent each year in campaigns for counternarcotic efforts in Afghanistan. At the same
time tribal elders and Afghan government ban on the illicit drug can also help to mitigate
cannabis and narcotics production and use in Afghanistan.
5. Drug screen regulation should be enacted both for the new recruits to arm forces of
Afghanistan and for drivers prior to issuing them driving license. This screening should
include urine and blood tests for narcotics and illicit drugs. In addition, drug and
psychiatric history should also be included in these screenings. Those who test positive
should not be employed or issued a driving license. They need to be treated properly
before recruitment and referred for proper counseling.
6. Teachers and parents can also play a positive role in cannabis use reduction, especially, in
teenagers. First teachers and parents need to be educated by health professionals and
public health workers about the negative health consequences of cannabis use. Based on
this awareness teachers can monitor students’ performance in schools and they can work

33

to gather with parents for the evaluation of students’ poor performance. If necessary they
can seek help from health professions. Parents can also play a major role in control or
prevention of cannabis use in their children. Parents need to establish a constructive
relationship with their children and need to discuss the issues of cannabis and smoking
with their children. They also need to monitor their children peers and their habits and
activities.
3.3 Summary and Conclusion

Afghanistan will become worlds the major cannabis producing country (UNODC,
Afghanistan Cannabis survey 2009). The prevalence of cannabis use in Afghanistan is 8.1
in male and 0.2 present in female (UNODC, Afghanistan Cannabis survey 2009).
Cannabis is widely used amongst police and army recruits as well as amongst public
transport drivers. According to Nordland & Wafa, (2010), 12-40 percent of Afghan
Police recruits tested positive for drug use which included marijuana, hashish and opiates.
Based on unofficial surveys, more than 70 percent of public transports drivers who are
driving on major highways are addicted to cannabis and other illicit drugs. Cannabis use
can be linked to various negative health outcomes, including but not limited to, increased
risk of schizophrenia, psychosis (hallucination and paranoia), impaired motor control and
consequent impairment of driving skills, negative educational attainment, and increased
crime rate; however, there are few studies available to measure the health consequences
of cannabis in Afghanistan. Despite data unavailability, observations indicate the highest
use of cannabis amongst drivers and increased rate of incidence of vehicle crashes,
increased use of cannabis and hostility in Afghan soldiers and their attacks on the their
local and international counter parts, and poor education attainment amongst students and
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security issues in cannabis plagued areas. There is a dire need for studies and research in
this domain for the evaluation of cannabis use and its health consequences in
Afghanistan.
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